What is the address of Buckman Laboratories?

The registered office of Buckman Laboratories is located at Wondelgemkaai 157, 9000 Gent.

Is Buckman Laboratories still active?

Yes. According to the CBE (30 October 2026) Buckman Laboratories is active, legal situation “Normale toestand”, started on 18 July 1963.

Is Buckman Laboratories registered on Peppol?

Yes, Buckman Laboratories is registered on the Peppol network with ID 0208:0401065997.

What is the enterprise number of Buckman Laboratories?

The enterprise number of Buckman Laboratories is BE0401065997.

When was Buckman Laboratories founded?

Buckman Laboratories was founded on 18 July 1963.

Who are the directors of Buckman Laboratories?

According to the 2025 annual accounts, the directors of Buckman Laboratories are: Martin Conner, Edward Jonathan Scharf, Bruno Launay, John Gustin.

Is Buckman Laboratories a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 July 1963; 5 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did Buckman Laboratories make in 2025?

Buckman Laboratories posted a profit after taxes of € 7,117,412 in financial year 2025.

What is the revenue of Buckman Laboratories?

In its most recent annual accounts (2025), Buckman Laboratories reported revenue of € 55,262,066.

How much does an employee at Buckman Laboratories earn?

The average wage cost per full-time employee at Buckman Laboratories was € 145,700 in 2025: staff costs of € 7 million for 48 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Buckman Laboratories have?

According to the 2025 annual accounts, Buckman Laboratories has 48 full-time equivalents (FTE).

Does Buckman Laboratories have a website?

Yes, Buckman Laboratories has a website at buckman.com.

Buckman Laboratories (Public Limited) - Gent

Q: What does Buckman Laboratories do?

Buckman Laboratories is registered with the CBE as active in: Vervaardiging van andere organische chemische basisproducten. Public Limited, started on 18 July 1963, 1 establishment.

Dossier Buckman Laboratories, printed on 30 October 2026 from databakkes.be/en/0401065997/buckman-laboratories. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Buckman Laboratories from Gent, company number BE0401065997, closed financial year 2025 with a result of € 7.1 million after tax. For that financial year Buckman Laboratories recorded revenue of € 55.3 million and equity of € 11.6 million. Compared with financial year 2024, the result moved from € 4.2 million to € 7.1 million. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Healthy

€ 11.6 million

▼ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 7.1 million

▲ 69% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 851,546

▼ 34% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 5 million paid out

70 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

▼ 1.9 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 7.3 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 7 million

▼ 9% vs 2024

€ 145,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 20,530

▼ 42% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4.9 million

▼ 7% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 46 days on average.

Taxes and wages

€ 3.3 million

▼ 2% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 64,273,273 Revenue 2022: € 64,273,273 First fiscal year in the series	€ 63,092,019 Revenue 2023: € 63,092,019 ▼ 2% vs 2022 (€ 64,273,273) Unfavourable step	€ 59,510,068 Revenue 2024: € 59,510,068 ▼ 6% vs 2023 (€ 63,092,019) Unfavourable step	€ 55,262,066 Revenue 2025: € 55,262,066 ▼ 7% vs 2024 (€ 59,510,068) Unfavourable step	▼ 7%
Profit after taxes	€ 3,988,775 Profit after taxes 2022: € 3,988,775 First fiscal year in the series	€ 391,862 Profit after taxes 2023: € 391,862 ▼ 90% vs 2022 (€ 3,988,775) Unfavourable step	€ 4,211,358 Profit after taxes 2024: € 4,211,358 ▲ € 3.8 million vs 2023 (€ 391,862) Favourable step	€ 7,117,412 Profit after taxes 2025: € 7,117,412 ▲ 69% vs 2024 (€ 4,211,358) Favourable step	▲ 69%
Equity	€ 19,606,275 Equity 2022: € 19,606,275 First fiscal year in the series	€ 18,177,536 Equity 2023: € 18,177,536 ▼ 7% vs 2022 (€ 19,606,275) Unfavourable step	€ 13,402,095 Equity 2024: € 13,402,095 ▼ 26% vs 2023 (€ 18,177,536) Unfavourable step	€ 11,597,561 Equity 2025: € 11,597,561 ▼ 13% vs 2024 (€ 13,402,095) Unfavourable step	▼ 13%
Total debts	€ 10,061,020 Total debts 2022: € 10,061,020 First fiscal year in the series	€ 7,636,343 Total debts 2023: € 7,636,343 ▼ 24% vs 2022 (€ 10,061,020) Favourable step	€ 11,360,965 Total debts 2024: € 11,360,965 ▲ 49% vs 2023 (€ 7,636,343) Unfavourable step	€ 16,577,454 Total debts 2025: € 16,577,454 ▲ 46% vs 2024 (€ 11,360,965) Unfavourable step	▲ 46%
Cash	€ 802,783 Cash 2022: € 802,783 First fiscal year in the series	€ 2,852,082 Cash 2023: € 2,852,082 ▲ 255% vs 2022 (€ 802,783) Favourable step	€ 1,288,305 Cash 2024: € 1,288,305 ▼ 55% vs 2023 (€ 2,852,082) Unfavourable step	€ 851,546 Cash 2025: € 851,546 ▼ 34% vs 2024 (€ 1,288,305) Unfavourable step	▼ 34%
Land & buildings	€ 1,528,738 Land & buildings 2022: € 1,528,738 First fiscal year in the series	€ 1,569,595 Land & buildings 2023: € 1,569,595 ▲ 3% vs 2022 (€ 1,528,738) Unchanged	€ 1,595,330 Land & buildings 2024: € 1,595,330 ▲ 2% vs 2023 (€ 1,569,595) Unchanged	€ 1,499,213 Land & buildings 2025: € 1,499,213 ▼ 6% vs 2024 (€ 1,595,330) Unchanged	▼ 6%
Retained profit	€ 18,698,984 Retained profit 2022: € 18,698,984 First fiscal year in the series	€ 17,270,246 Retained profit 2023: € 17,270,246 ▼ 8% vs 2022 (€ 18,698,984) Unfavourable step	€ 12,494,805 Retained profit 2024: € 12,494,805 ▼ 28% vs 2023 (€ 17,270,246) Unfavourable step	€ 10,690,271 Retained profit 2025: € 10,690,271 ▼ 14% vs 2024 (€ 12,494,805) Unfavourable step	▼ 14%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 1,820,600 Dividend 2023: € 1,820,600 Unchanged (€ 0) Unchanged	€ 2,500,000 Dividend 2024: € 2,500,000 ▲ 37% vs 2023 (€ 1,820,600) Unchanged	€ 5,000,000 Dividend 2025: € 5,000,000 ▲ 100% vs 2024 (€ 2,500,000) Unchanged	▲ 100%
Balance sheet total	€ 29,667,295 Balance sheet total 2022: € 29,667,295 First fiscal year in the series	€ 25,813,879 Balance sheet total 2023: € 25,813,879 ▼ 13% vs 2022 (€ 29,667,295) Unchanged	€ 24,763,060 Balance sheet total 2024: € 24,763,060 ▼ 4% vs 2023 (€ 25,813,879) Unchanged	€ 28,175,015 Balance sheet total 2025: € 28,175,015 ▲ 14% vs 2024 (€ 24,763,060) Unchanged	▲ 14%
Employees (FTE)	58.2 Employees (FTE) 2022: 58.2 First fiscal year in the series	50.2 Employees (FTE) 2023: 50.2 ▼ 8 vs 2022 (58.2) Unchanged	49.9 Employees (FTE) 2024: 49.9 ▼ 0.3 vs 2023 (50.2) Unchanged	48 Employees (FTE) 2025: 48 ▼ 1.9 vs 2024 (49.9) Unchanged	▼ 1.9

Key figures of Buckman Laboratories, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Buckman Laboratories?

What happened at Buckman Laboratories in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Martin Conner stepped down as director. NBB
2029 John Gustin stepped down as director. NBB
Jul 22, 2026 New annual accounts for financial year 2025: profit of € 7.1 million (▲ 69% vs 2024). Source: NBB ↗
2026 Edward Jonathan Scharf stepped down as director. NBB
2026 Bruno Launay stepped down as director. NBB
2024 Martin Conner became a director. NBB
2023 John Gustin became a director. NBB
2020 Edward Jonathan Scharf became a director. NBB

In short

From € 4 million profit in 2022 to € 7.1 million profit in 2025.

Paid € 5.6 million in corporate taxes since 2022.

Best year ever: 2025, with € 7.1 million profit.

Paid out € 9.3 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Buckman Laboratories

Buckman laboratories Gmbh 100%

Buckman Laboratories AB 100%

Buckman Laboratories Italiana 100%

Buckman Laboratories Ltd 100%

It owns 100% of Buckman laboratories Gmbh, 100% of Buckman Laboratories AB, 100% of Buckman Laboratories Italiana, 100% of Buckman Laboratories Ltd, 100% of Buckman laboratories Iberica S.A. and 100% of Buckman Laboratories Gmbh itself.

Directors

According to the 2025 annual accounts

Martin Conner

Director

since 2024 · until 2029

Edward Jonathan Scharf

Director

since 2020 · until 2026

Bruno Launay

Director

since 2020 · until 2026

John Gustin

Managing director

since 2023 · until 2029

Establishments

Establishment units

Physical locations of this company

Registered office

Wondelgemkaai 157

9000 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS buckman.com

Canonical: https://www.buckman.com/

Technologies

Cloudflare CDNContact Form 7CookieYesGoogle AnalyticsGoogle Tag ManagerPHPSlickVimeoWPMLWordPressYoast SEOjQuery

Certifications & Partners

FEB/VBO

Hosting & Email

Email provider

Microsoft 365

Hosting

CLOUDFLARESPECTRUM Cloudflare, Inc., US

Domain

buckman.com

Registered

1994-06-27

Registrar

Network Solutions, LLC

Expires

2031-06-26

Website info

HTTPS Ja

Languages EN, FR

Features

Webshop Blog Ads

Security

✓ HTTPS

✗ SPF

✓ DMARC

Network

✓ Load balancing

Details

Company number

0401.065.997

VAT number

BE 0401.065.997

Registered office

Wondelgemkaai 157, 9000 Gent

Names & denominations

Buckman Laboratories

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

18 July 1963

Peppol

Active · Active since 19 Dec 2025

Contact

buckman.com

Activities · NACE

Vervaardiging van andere organische chemische basisproducten

Vervaardiging van overige organische chemische basisproducten

Vervaardiging van andere chemische producten, neg

Vervaardiging van overige chemische producten

Vervaardiging van geneesmiddelen

View on CBE Public ↗ Annual accounts (NBB) ↗

Buckman Laboratories

Financials

What happened to Buckman Laboratories?

Management

Directors

Establishments

Establishment units

Website

Technologies

Certifications & Partners

Hosting & Email

Domain

Website info

Features

Security

Network

Details

Frequently asked questions